scispace - formally typeset
Search or ask a question
Journal ArticleDOI

Sequencing technologies-the next generation

01 Jan 2010-Nature Reviews Genetics (Nature Publishing Group)-Vol. 11, Iss: 1, pp 31-46
TL;DR: A technical review of template preparation, sequencing and imaging, genome alignment and assembly approaches, and recent advances in current and near-term commercially available NGS instruments is presented.
Abstract: Demand has never been greater for revolutionary technologies that deliver fast, inexpensive and accurate genome information. This challenge has catalysed the development of next-generation sequencing (NGS) technologies. The inexpensive production of large volumes of sequence data is the primary advantage over conventional methods. Here, I present a technical review of template preparation, sequencing and imaging, genome alignment and assembly approaches, and recent advances in current and near-term commercially available NGS instruments. I also outline the broad range of applications for NGS technologies, in addition to providing guidelines for platform selection to address biological questions of interest.

Summary (1 min read)

Jump to:  and [Summary]

Summary

  • DNA sequencing is one of the most important platforms for study in biological systems today.
  • The high-throughput-next generation sequencing technologies delivers fast, inexpensive, and accurate genome information.
  • Next generation sequencing can produce over 100 times more data than methods based on Sanger Sequencing.
  • The next generation sequencing technologies offered from Illumina / Solexa, ABI/SOLiD, 454/Roche, and Helicos has provided unprecedented opportunity for high-throughput functional genomic research.
  • Next generation sequence technologies offer novel and rapid ways for genome-wide characterization and profiling of mRNA's, transcription factor regions, and DNA patterns.

Did you find this useful? Give us your feedback

Content maybe subject to copyright    Report

TEMPLATE DESIGN © 2008
www.PosterPresentations.com
ABSTRACT
Conclusion and Future Work
Next Generation Sequencing
CONTACT INFO
Data Analysis Comparisons
Downstream Analysis
REFERENCES
DNA sequencing is one of the most important platforms for
study in biological systems today. The high-throughput-next
generation sequencing technologies delivers fast,
inexpensive, and accurate genome information. Next
generation sequencing can produce over 100 times more data
than methods based on Sanger Sequencing. The next
generation sequencing technologies offered from Illumina /
Solexa, ABI/SOLiD, 454/Roche, and Helicos has provided
unprecedented opportunity for high–throughput functional
genomic research. Next generation sequence technologies
offer novel and rapid ways for genome-wide characterization
and profiling of mRNAs, transcription factor regions, and DNA
patterns.
Fig. 7) This is a plot of the frequency of each percentage covered for all nodes.
BLAST is in blue, MUMmer is in green.
Sequencing Technologies – the Next Generation,
Micahel L. Metzkerh
Next Generation Sequencing Pipeline Development and Data Analysis
Fig. 9) This is a plot of the coverage of each Node. BLAST points are blue,
MUMmer points are red.
Fig. 6) This is a plot of the frequency of each percentage covered for all contigs.
BLAST is in blue, MUMmer is in green.
454/Roche – 454 Life Sciences is a Biotechnology company
that is a part of Roche and based in Branford, Connecticut.
The center develops ultra-fast high-throughput DNA
sequencing methods and tools.
Illumina/Solexa– Illumina is a company that develops and
manufactures integrated systems for the analysis of gene
variation. Solexa was founded to develop genome
sequencing technology.
ABI/SOLiD - (Sequencing by Oligonucleotide Ligation and
Detection) is a next-generation DNA sequencing technology
developed by Life Technologies and has been commercially
available since 2006. This next generation technology
generates hundreds of millions to billions of small sequence
reads at one time.
Helicos - Helicos's technology images the extension of
individual DNA molecules using a defined primer and
individual fluorescently labeled nucleotides, which contain a
"virtual terminator" preventing incorporation of multiple
nucleotides per cycle.
Julian Pierre
1
, Jordan Taylor
2
, Amit Upadhyay
3
, Bhanu Rekepalli
3
Fig. 8) This is a plot of the coverage of each Contig. BLAST points are blue,
MUMmer points are red.
Using the coverage of
each individual contig
ID, the results for both
BLAST and MUMmer
were plotted. While
BLAST hit more contigs,
there are more contigs
with a higher coverage
that were hit by
MUMmer.
Using the data gathered
from both BLAST and
MUMmer, the frequency
of the amount covered
for each contig was
plotted. From Fig 6), it
can be inferred that
MUMmer hit more
accurately for contigs.
Fig 4) from main.g2.bx.psu.edu
Once the results were found using both the BLAST and
MUMmer search tools, we created a program to see which
sequencing tool had the most hits per contig. The total
number of contigs in the database file is 160,749 and the
total number of nodes in the query file is 552,305. BLAST
returned a total of 123,070 hits and MUMmer returned a
total of 121,829 hits. From the results, MUMmer hit more
accurately than BLAST while BLAST hit more contigs than
MUMmer.
In Next-Generation Sequencing, data analysis is one of the
most expensive processes. While the cost of genome
sequencing goes down, the cost of analyzing data is still
expensive. In the future, the “$1,000 genome will come with
a $20,000 analysis price tag.”
The same process was
done with the Nodes.
From Fig 7), it can be
inferred that BLAST hit
more accurately with
nodes. However, there
are more BLAST results
with lower coverage.
The future of next generation sequencing can be broken
down into a variety of categories such as personalized
medicine, bio fuels, climate change, and other life science
fields.
Personalized Medicine is a medical model that proposes
the customization of medical decision to tailor an
individual
Bio Fuels present a source of alternative energy.
Microalgal biofuels use algae to synthesize the fuel. In
order to optimize the process, an understanding of the
gene-function relationship of algae would prove helpful.
Climate change is the active study of past and future
theoretical models which uses the past climate data to
make future projections.
In conclusion, we hope to contribute the knowledge we
have gained to contribute to fields such as these.
The same process was
done with the Nodes.
While BLAST hit more
Nodes, there are more
Nodes that hit with a
lower coverage using
BLAST.
1 Texas Southern University, 2 Austin Peay State University, 3 University of Tennessee
Next Gen Sequencing uses a wide array of tools to obtain results based
on the genome sequence. The most widely used Tools are BLAST,
HMMER, and MUMmer.
BLAST (Basic Local Alignment Search Tool) is a multi-sequence
alignment tool developed by NIH (National Institute of Health). It is
used find similar regions in different sequences and then compare
their similarities.
MUMmer (Maximum Unique Matches) is a rapid alignment system
used for rapidly aligning entire genomes. It can also align incomplete
genomes and can easily handle 1000’s of contigs from a shotgun
sequencing project.
HMMER (Hidden Markov Modeler) is used for searching sequence
databases for homologs of protein sequences, and for making protein
sequence alignments. It implements methods using probabilistic
models called profile hidden Markov models (HMMs)
Genome Assembly
Sequence Analysis refers to
the process of subjecting a
DNA, RNA or peptide
sequence to a wide range of
analytical methods to:
Compare sequences to find
similarities and infer if they
are Homologous
To identify the features of
the sequence such as gene
structure, distribution,
introns and exons, and
regulation of gene
expression
Identify Sequence
differences and variations
such as mutations
Fig. 1) This is figure shows three different Next Generation Sequencing methods. [2]
Fig. 2) Taken from A Hitchhiker’s Guide to Next-Generation Sequencing, by Gabe Rudy
Fig. 3) Taken from bio.davidson.edu/courses. Shows alignment results for yeast.
Fig 5) from jcvi.org shows the mapping of chr6 of a Human Genome
Julian Pierre – julz_pierre@yahoo.com
Jordan Taylor – jtaylor74@my.apsu.edu
Amit Upadhyay – aupadhy1@utk.edu
Bhanu Rekepalli – brekapal@utk.edu
http://www.roche.com/research_and_development/r_d_overview/
r_d_sites.htm?id=18
http://www.pnas.org/content/99/6/3712/F1.expansion.html
http://www.yerkes.emory.edu/nhp_genomics_core/Services/
Sequencing.html
http://www.illumina.com/technology/solexa_technology.ilmn
http://blast.ncbi.nlm.nih.gov/Blast.cgi
https://main.g2.bx.psu.edu/u/dan/p/fastq
http://ori.dhhs.gov/education/products/n_illinois_u/datamanagement/
datopic.htmll
http://www.jcvi.org/medicago/include/images/chr6.BamHI.maps.jpg
Gabe Rudy, (2010) A Hitchhikers Guide to Next-Generation
Sequencing, :1-9, Golden Helix
[1] John D. McPherson, (2009) Next-Generation Gap, 6:1-4, Nature
Methods Supplement
[2]Michael L. Metzker, (2010) Sequencing Technologies, - the next
generation, 11:1-5, Nature Reviews
Md. Fakruddin,Khanjada Shahnewaj Bin mannan, (2012) Next
Generation sequencing technologies – Principles and prospects,
6:1-9, Research and Reviews in Biosciences
Misra N., Panda P. K., Parida B. K., Mishra B. K., (2012)
Phylogenomic Study of Lipid Genes Involved in Mocroalgal Biofuel
Production – Candidate Gene Mining and Metabolic Pathway
Analyses, Evolutionary Bioinformatics 8:545-564, doi: 10.4137/
EBO.S10159
Galaxy is an open, web-based
platform for data intensive
biomedical research. It can be
used on its own free public
server where you can perform,
reproduce, and share complete
analyses.
An example of how Galaxy
reflects its data is shown in Fig 5.
Two FASTA files related to the same nucleotide sequence
were input into both BLAST and MUMmer and the results
were parsed into tables. Then, the coverage of all hit contigs
and nodes from both programs was found.
Citations
More filters
Journal ArticleDOI
TL;DR: Three important tools for predicting gene regulation and function in honey bees are described: Fluorescence in situ hybridization (FISH), RNA interference (RNAi), and the estimation of chromosomal methylation and its role in epigenetic gene regulation.
Abstract: SummaryFrom studies of behaviour, chemical communication, genomics and developmental biology, among many others, honey bees have long been a key organism for fundamental breakthroughs in biology. With a genome sequence in hand, and much improved genetic tools, honey bees are now an even more appealing target for answering the major questions of evolutionary biology, population structure, and social organization. At the same time, agricultural incentives to understand how honey bees fall prey to disease, or evade and survive their many pests and pathogens, have pushed for a genetic understanding of individual and social immunity in this species. Below we describe and reference tools for using modern molecular-biology techniques to understand bee behaviour, health, and other aspects of their biology. We focus on DNA and RNA techniques, largely because techniques for assessing bee proteins are covered in detail in Hartfelder et al. (2013). We cover practical needs for bee sampling, transport, and storage, an...

162 citations

Journal ArticleDOI
TL;DR: How different Next Gen Sequencing platforms, as well as recent advances in NGS based high throughput genotyping technologies are rewarding efforts on de-novo whole genome/transcriptome sequencing, development of genome wide sequence based markers resources for improvement of non-model crops that are less costly than phenotyping is explored.
Abstract: Non-model plants i.e., the species which have one or all of the characters such as long life cycle, difficulty to grow in the laboratory or poor fecundity, have been schemed out of sequencing projects earlier, due to high running cost of Sanger sequencing. Consequently, the information about their genomics and key biological processes are inadequate. However, the advent of fast and cost effective next generation sequencing platforms in the recent past has enabled the unearthing of certain characteristic gene structures unique to these species. It has also aided in gaining insight about mechanisms underlying processes of gene expression and secondary metabolism as well as facilitated development of genomic resources for diversity characterization, evolutionary analysis and marker assisted breeding even without prior availability of genomic sequence information. In this review we explore how different Next Gen Sequencing platforms, as well as recent advances in NGS based high throughput genotyping technologies are rewarding efforts on de-novo whole genome/ transcriptome sequencing, development of genome wide sequence based markers resources for improvement of non-model crops that are less costly than phenotyping .

162 citations


Cites background from "Sequencing technologies-the next ge..."

  • ...According to Metzker (2010), they include a number of methods grouped broadly as template preparation, sequencing and imaging, and data analysis in which protocol distinguishes one technology from another and by the amount of the data produced from each platform....

    [...]

Journal ArticleDOI
TL;DR: Easy work-flow, high throughput multiplexing capability, 4-day turnaround time and simultaneous assessment of routinely tested and emerging markers make MiSeq highly applicable for clinical molecular testing in acute myeloid leukemia.
Abstract: Routine molecular testing in acute myeloid leukemia involves screening several genes of therapeutic and prognostic significance for mutations A comprehensive analysis using single-gene assays requires large amounts of DNA, is cumbersome and timely consolidation of results for clinical reporting is challenging High throughput, next-generation sequencing platforms widely used in research have not been tested vigorously for clinical application Here we describe the clinical application of MiSeq, a next-generation sequencing platform to screen mutational hotspots in 54 cancer-related genes including genes relevant in acute myeloid leukemia (NRAS, KRAS, FLT3, NPM1, DNMT3A, IDH1/2, JAK2, KIT and EZH2) We sequenced 63 samples from patients with acute myeloid leukemia/myelodysplastic syndrome using MiSeq and compared the results with those obtained using another next-generation sequencing platform, Ion-Torrent Personal Genome Machine and other conventional testing platforms MiSeq detected a total of 100 single nucleotide variants and 23 NPM1 insertions that were confirmed by Ion Torrent or conventional platforms, indicating complete concordance FLT3-internal tandem duplications (n=10) were not detected; however, re-analysis of the MiSeq output by Pindel, an indel detection algorithm, did detect them Dilution studies of cancer cell-line DNA showed that the quantitative accuracy of mutation detection was up to an allelic frequency of 15% with a high level of inter- and intra-run assay reproducibility, suggesting potential utility for monitoring response to therapy, clonal heterogeneity and evolution Examples demonstrating the advantages of MiSeq over conventional platforms for disease monitoring are provided Easy work-flow, high throughput multiplexing capability, 4-day turnaround time and simultaneous assessment of routinely tested and emerging markers make MiSeq highly applicable for clinical molecular testing in acute myeloid leukemia

161 citations


Cites background from "Sequencing technologies-the next ge..."

  • ...The massively parallel sequencing ability of NGS technologies has made high throughput and multiplexed sequencing of specific panels of genes or whole exomes/genomes feasible.(13-15) These technologies are currently being applied extensively to characterize genomic alterations in cancer(16-19) and are highly relevant for diagnostic purposes as alternatives to first-generation sequencing techniques....

    [...]

Journal ArticleDOI
TL;DR: This work proposes to solve the nomenclature dilemma by defining mutations as DNA variants obtained in a paired sequencing project including the germline DNA of the same individual as a reference, accompanied by a qualifying prefix indicating whether the mutation occurs only in somatic cells (somatic mutation) or also in the germ line (germline mutation).
Abstract: The growing advances in DNA sequencing tools have made analyzing the human genome cheaper and faster While such analyses are intended to identify complex variants, related to disease susceptibility and efficacy of drug responses, they have blurred the definitions of mutation and polymorphism In the era of personal genomics, it is critical to establish clear guidelines regarding the use of a reference genome Nowadays DNA variants are called as differences in comparison to a reference In a sequencing project Single Nucleotide Polymorphisms (SNPs) and DNA mutations are defined as DNA variants detectable in >1 % or <1 % of the population, respectively The alternative use of the two terms mutation or polymorphism for the same event (a difference as compared with a reference) can lead to problems of classification These problems can impact the accuracy of the interpretation and the functional relationship between a disease state and a genomic sequence We propose to solve this nomenclature dilemma by defining mutations as DNA variants obtained in a paired sequencing project including the germline DNA of the same individual as a reference Moreover, the term mutation should be accompanied by a qualifying prefix indicating whether the mutation occurs only in somatic cells (somatic mutation) or also in the germline (germline mutation) We believe this distinction in definition will help avoid confusion among researchers and support the practice of sequencing the germline and somatic tissues in parallel to classify the DNA variants thus defined as mutations

161 citations


Cites background from "Sequencing technologies-the next ge..."

  • ...The increasing competition among these companies has resulted in many different technologies, which are now available to facilitate new insights into genomics [11]....

    [...]

  • ...The new sequencing technologies continue to become cheaper and more precise, and facilitate novel medical and biological breakthroughs all over the world [10, 11]....

    [...]

Journal ArticleDOI
TL;DR: The rapid production (and analysis) of droplets allows for exceptionally high-throughput experimentation and data acquisition, and configurable channel designs, coupled with on-demand control architectures, engender a range of robust manipulations.
Abstract: Microfluidic platforms have changed the paradigm of biochemical experimentation over the past three decades. Prominent within this technology set are droplet-based microfluidic systems, in which passive microfluidic structures are used to rapidly generate and manipulate sub-nanoliter volumes droplets within microchannel environments. Droplets are formed in a continuous and robust fashion through the extrusion and shearing of two mutually immiscible phases in a microchannel, with droplet volumes being precisely controlled through the variation of flow rate ratios and channel dimensions. The rapid production (and analysis) of droplets allows for exceptionally high-throughput experimentation and data acquisition, and configurable channel designs, coupled with on-demand control architectures, engender a range of robust manipulations, such as reagent dosing, droplet fusion, droplet splitting, washing, payload heating, incubation, content dilution and droplet sorting. Accordingly, and unsurprisingly, droplet-based microfluidic systems have become an indispensable and embedded tool within contemporary chemical and biological science.

161 citations

References
More filters
Journal ArticleDOI
TL;DR: The RNA-Seq approach to transcriptome profiling that uses deep-sequencing technologies provides a far more precise measurement of levels of transcripts and their isoforms than other methods.
Abstract: RNA-Seq is a recently developed approach to transcriptome profiling that uses deep-sequencing technologies. Studies using this method have already altered our view of the extent and complexity of eukaryotic transcriptomes. RNA-Seq also provides a far more precise measurement of levels of transcripts and their isoforms than other methods. This article describes the RNA-Seq approach, the challenges associated with its application, and the advances made so far in characterizing several eukaryote transcriptomes.

11,528 citations


"Sequencing technologies-the next ge..." refers background in this paper

  • ...For example, in gene-expression studies microarrays are now being replaced by seq-based methods , which can identify and quantify rare transcripts without prior knowledge of a particular gene and can provide information regarding alternative splicing and sequence variation in identified gene...

    [...]

Journal ArticleDOI
TL;DR: Velvet represents a new approach to assembly that can leverage very short reads in combination with read pairs to produce useful assemblies and is in close agreement with simulated results without read-pair information.
Abstract: We have developed a new set of algorithms, collectively called "Velvet," to manipulate de Bruijn graphs for genomic sequence assembly. A de Bruijn graph is a compact representation based on short words (k-mers) that is ideal for high coverage, very short read (25-50 bp) data sets. Applying Velvet to very short reads and paired-ends information only, one can produce contigs of significant length, up to 50-kb N50 length in simulations of prokaryotic data and 3-kb N50 on simulated mammalian BACs. When applied to real Solexa data sets without read pairs, Velvet generated contigs of approximately 8 kb in a prokaryote and 2 kb in a mammalian BAC, in close agreement with our simulated results without read-pair information. Velvet represents a new approach to assembly that can leverage very short reads in combination with read pairs to produce useful assemblies.

9,389 citations

Journal ArticleDOI
15 Sep 2005-Nature
TL;DR: A scalable, highly parallel sequencing system with raw throughput significantly greater than that of state-of-the-art capillary electrophoresis instruments with 96% coverage at 99.96% accuracy in one run of the machine is described.
Abstract: The proliferation of large-scale DNA-sequencing projects in recent years has driven a search for alternative methods to reduce time and cost. Here we describe a scalable, highly parallel sequencing system with raw throughput significantly greater than that of state-of-the-art capillary electrophoresis instruments. The apparatus uses a novel fibre-optic slide of individual wells and is able to sequence 25 million bases, at 99% or better accuracy, in one four-hour run. To achieve an approximately 100-fold increase in throughput over current Sanger sequencing technology, we have developed an emulsion method for DNA amplification and an instrument for sequencing by synthesis using a pyrosequencing protocol optimized for solid support and picolitre-scale volumes. Here we show the utility, throughput, accuracy and robustness of this system by shotgun sequencing and de novo assembly of the Mycoplasma genitalium genome with 96% coverage at 99.96% accuracy in one run of the machine.

8,434 citations

Journal ArticleDOI
20 Feb 2009-Cell
TL;DR: This work has revealed unexpected diversity in their biogenesis pathways and the regulatory mechanisms that they access, which has direct implications for fundamental biology as well as disease etiology and treatment.

4,490 citations


"Sequencing technologies-the next ge..." refers background in this paper

  • ...and to elucidate the role of non-coding RNAs in health and diseas...

    [...]

Journal ArticleDOI
20 Feb 2009-Cell
TL;DR: The evolution of long noncoding RNAs and their roles in transcriptional regulation, epigenetic gene regulation, and disease are reviewed.

4,277 citations


"Sequencing technologies-the next ge..." refers background in this paper

  • ...and to elucidate the role of non-coding RNAs in health and diseas...

    [...]